Notice of Intent to Sole Source.pdf
PDF 135 KB Posted
- Solicitation number
- FDA-RFQ-CFSAN-2024-124037
About this file
This document is a Notice of Intent to Sole Source, issued by the Food and Drug Administration (FDA) for the procurement of a Berthold NightSHADE in vivo Plant Imaging System plus 4 years of Preventative Maintenance Agreement (PMA), under Solicitation FDA-RFQ-CFSAN-2024-124037.
The FDA intends to award a sole source, fixed-price purchase order to Berthold Technologies USA, LLC, the sole manufacturer and supplier of the required equipment. The FDA has determined that the Berthold NightSHADE system is the only product technically acceptable for their needs, with no other comparable offerings on the market. Any parties capable of meeting this requirement may submit capability statements by the response date of June 18, 2024, 12:00 PM EST. The FDA will review submissions to determine if they can meet the requirement, and a contract award to Berthold Technologies is anticipated within 15 days after the notice date, unless the government determines that another organization has the capacity to fulfill the need.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Notice of Intent to Sole Source
Subject: Fixed Price (FFP) Purchase Order Type for the procurement of: CFSAN-2024-124037- Berthold NightSHADE in vivo Plant Imaging System plus 4 (four) Years (12 Months each) of Preventative Maintenance Agreement (PMA). Sole Source, under Solicitation: FDA-RFQ-CFSAN- 2024-124037.
Notice of Intent to Sole Source to: Berthold Technologies USA, LLC.
Pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 6.302-1, (there is only one responsible source, and no other supplies or services will satisfy agency requirements). The Food and Drug Administration (FDA) intends to award a Sole Source Fixed Price (FFP) Purchase Order Type to Berthold Technologies USA, LLC., located at:
Berthold Technologies USA, LLC Bio-Analytical Division 016 99 Midway Lane Oak Ridge, TN 37830 Phone: 865-483-1488 Fax: 865-425-4309 Web: www.berthold.com Email: info[at]berthold.com
FDA seeks to purchase the Berthold NightSHADE in vivo Plant Imaging System plus 4 (four) Years (12 Months each) of Preventative Maintenance Agreement (PMA), Sole Source, under Solicitation:
FDA-RFQ-CFSAN-2024-124037, and the items are solely distributed by the manufacturer/subsidiaries and official distributors, with no thirty party re-sellers.
This vendor is the sole manufacturer and supplier for this instrument, which is technically acceptable for FDA’s needs.
In a sole source letter provided to FDA the manufacturer notes:
“Berthold Technologies USA LLC is the sole distributor of the LB985N that is manufactured by our headquarters in Germany, Berthold Technologies GmbH & Co. KG. The NightShade LB985N is a unique instrument on the market with no other companies offering features that are listed on a separate sheet.”
The associated NAICS 34516-Analytical Laboratory Instrument Manufacturing. Offerors must have an active registration in www.SAM.gov, with completed representations and certifications, by the close date of the solicitation.
This notice is not a request for competitive proposals. However, any party that believes it is capable of meeting this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement. Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.
It is anticipated that an award will be issued to Berthold Technologies USA, LLC., within approximately fifteen (15) days after the date of this notice unless the Government determines that any other organization has the capacity to meet this requirement.
Response Date: 12:00 p.m. EST 06/18/2024. Please email responses to Emmanuel Mbah at Emmanuel.mbah@fda.hhs.gov mailto:Emmanuel.mbah@fda.hhs.gov
File details come from the government source that posted it. Updated .